Umbilical cord blood approved stem cell therapies


First used
Cord blood stem cells were first successfully transplanted in 1988, and now it is used to treat over 80 blood-related diseases.


  • Acute Lymphoblastic Leukaemia (ALL)
  • Acute Myeloid Leukaemia (AML)
  • Chronic Myeloid Leukaemia (CML)
  • Myelodysplastic Syndrome (MDS)
  • Multiple Myeloma
  • Hodgkin’s Lymphoma
  • Non-Hodgkin’s Lymphoma
  • Bone marrow failure syndromes
  • Severe Aplastic Anaemia, Unspecified
  • Fanconi Anaemia


  • Sickle Cell Disease
  • Thalassemia


  • Severe Combined Immune
  • Deficiency (SCID)
  • Wiskott-Aldrich Syndrome


  • Hurler Disease (MPS type IH)
  • Osteopetrosis
  • Adrenoleukodystrophy
  • Krabbe Disease


  • Systemic Lupus (SLE)

Seven-year-old Gina Rugari is a living example of how cord blood stem cell research is helping children born with Krabbe, a genetic disorder that almost always results in death before age two. Gina’s life was saved through a cord blood stem cell treatment.

Erik Praskins speaks at the Arizona Cord Blood Conference 2017 about the importance of cord blood donors. His son, Dylan, was diagnosed with leukaemia as a baby. He received a cord blood transplant just prior to turning 6 months old. That transplant saved his life. He is now a young boy, attending school and enjoying all of the activities a young child his age loves.

Deathly sick with Hodgkin’s Lymphoma and facing the 5th recurrence of the disease, Diane Paradise pushed doctors to help her. Educated about her options and her own body, she opted to participate in a clinical trial with cord blood instead of pursuing the usual bone marrow transplant and extended chemotherapy. This was a choice she does not regret. Diane is living proof that #WeCanICan: Beat Cancer with Cord Blood.


National Cord Blood Program,